Rethinking the management of immune checkpoint inhibitor‐related adrenal insufficiency in cancer patients during the COVID‐19 pandemic

INTRODUCTION: The coronavirus disease 2019 (COVID‐19) is currently a major pandemic challenge, and cancer patients are at a heightened risk of severity and mortality from this infection. In recent years, immune checkpoint inhibitor (ICI) use to treat multiple cancers has increased in oncology, but e...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuen, Kevin C. J., Mortensen, Michael J., Azadi, Amir, Fonkem, Ekokobe, Findling, James W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250331/
https://www.ncbi.nlm.nih.gov/pubmed/34268454
http://dx.doi.org/10.1002/edm2.246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250331/
https://www.ncbi.nlm.nih.gov/pubmed/34268454
http://dx.doi.org/10.1002/edm2.246

Ejemplares similares